Trial
NCT01739556
On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Clinical Centre of Serbia
Collaborators
—
Condition
Acute ST-elevation Myocardial Infarction
Intervention
Antiplatelet Regimen Modification (aspirin or ticagrelor)
Why stopped
An interim analysis showed that there is no difference in the primary endpoint, given the small number of events in the groups examined.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-18